605507 Guobang Pharma Ltd.
- 21.53
- -0.75-3.37%
Guobang Pharma Ltd. News
Guobang Pharmaceutical: Guobang Pharmaceutical\'s progress announcement on the repurchase of shares through centralized bidding
Guobang Pharmaceutical\'s Announcement on the Company\'s Wholly-owned Subsidiary Obtaining CEP Certificates for APIs
Announcement of Guobang Pharmaceutical on the receipt of a notice of approval for the listing application for chemical raw materials by its wholly-owned subsidiary
Guobang Pharmaceutical: Guobang Pharmaceutical\'s progress announcement on the repurchase of shares through centralized bidding
Announcement of the resolution of the first holder meeting of the first phase employee stock ownership plan of Guobang Pharmaceutical.
Announcement on the completion of non-trading transfer and purchase of the first phase of the employee stock ownership plan by Guobang Pharmaceutical
Announcement on the implementation progress of the first phase employee stock ownership plan of Guobang Pharmaceutical.
Announcement on the implementation progress of the first phase employee stock ownership plan of Guobang Pharmaceutical.
Guobang Pharmaceutical's first phase employee stock ownership plan.
Legal Opinion of Guohao Law Firm (Hangzhou) Regarding the First Extraordinary General Meeting of Shareholders of Guobang Pharmaceutical Co., Ltd. in 2024
Announcement of the resolutions of the first extraordinary shareholders' meeting of Guobang Pharmaceutical in 2024.
Announcement of the resolution of the National Pharmaceutical Employee Congress.
Draft of the first phase of Guobang Pharmaceutical's employee shareholding plan.
Summary of the first phase of the Guobang Pharmaceutical Employee Stock Ownership Plan (Draft).
Materials for the first extraordinary general meeting of shareholders of Guobang Pharmaceutical in 2024.
Notice on Convening the First Extraordinary Shareholders' Meeting of Guobang Pharmaceutical Co., Ltd. in 2024.
Announcement of Resolutions of Guobang Pharmaceutical's 2023 Annual General Meeting of Shareholders
Legal Opinion of Guohao Lawyers (Hangzhou) Firm on the 2023 Annual General Meeting of Shareholders of Guobang Pharmaceutical
Guobang Pharmaceutical\'s announcement on the launch of foreign exchange hedging business by the company and its subsidiaries
Announcement of Guobang Pharmaceutical on amending the “Articles of Association” and registration of industrial and commercial changes
Analysis
Price Target
No Data
No Data